Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin

NCT07060456 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HRS9531
DRUG: HRS9531
DRUG: Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.